149 related articles for article (PubMed ID: 31190803)
1. Targeted nanoparticle-mediated LHPP for melanoma treatment.
Zhang Q; Xiong M; Liu J; Wang S; Du T; Kang T; Liu Y; Cheng H; Huang M; Gou M
Int J Nanomedicine; 2019; 14():3455-3468. PubMed ID: 31190803
[No Abstract] [Full Text] [Related]
2. Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.
Liu J; Yang L; Yuan X; Xiong M; Zhu J; Wu W; Ren M; Long J; Xu X; Gou M
Int J Nanomedicine; 2021; 16():7697-7709. PubMed ID: 34819728
[TBL] [Abstract][Full Text] [Related]
3. The histidine phosphatase LHPP: an emerging player in cancer.
Wu F; Ma H; Wang X; Wei H; Zhang W; Zhang Y
Cell Cycle; 2022 Jun; 21(11):1140-1152. PubMed ID: 35239447
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
5. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway.
Wang D; Ning Z; Zhu Z; Zhang C; Wang P; Meng Z
Int J Biochem Cell Biol; 2021 Mar; 132():105845. PubMed ID: 33401010
[TBL] [Abstract][Full Text] [Related]
6. LHPP promotes the intracellular reactive oxygen species accumulation and sensitivity of gastric cancer to cisplatin via JNK and p38 MAPK pathways.
Gao K; Yin N; Shen Z; Li Q; Chen P; Yang K
Histol Histopathol; 2023 Sep; 38(9):1055-1068. PubMed ID: 36546683
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
Zheng J; Dai X; Chen H; Fang C; Chen J; Sun L
Biochem Biophys Res Commun; 2018 Sep; 503(2):1108-1114. PubMed ID: 29944886
[TBL] [Abstract][Full Text] [Related]
9. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
Li Y; Zhang X; Zhou X; Zhang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
[TBL] [Abstract][Full Text] [Related]
10. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B
Lu N; Li R; Liu Q; Hu B; Xu X; Ji C; Han X; Wang P; Liu B
Drug Deliv; 2016 Sep; 23(7):2566-2574. PubMed ID: 26000825
[TBL] [Abstract][Full Text] [Related]
13. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer.
Zhang Z; Wang X; Liu Y; Wu H; Zhu X; Ye C; Ren H; Chong W; Shang L; Li L
MedComm (2020); 2024 Feb; 5(2):e472. PubMed ID: 38292328
[TBL] [Abstract][Full Text] [Related]
14. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses human esophageal cancer cell growth by inducing mitotic catastrophe through the P27/cyclin A/CDK2 signaling pathway.
Ruifang D; Changqing Y; Chenxia R; Ji L; Zibai W
Acta Histochem; 2023 Aug; 125(6):152066. PubMed ID: 37348327
[TBL] [Abstract][Full Text] [Related]
15. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
16. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma.
Soleimani AH; Garg SM; Paiva IM; Vakili MR; Alshareef A; Huang YH; Molavi O; Lai R; Lavasanifar A
Drug Deliv Transl Res; 2017 Aug; 7(4):571-581. PubMed ID: 28290050
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
18. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
Xiong W; Peng L; Chen H; Li Q
Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo.
Kiran Rompicharla SV; Trivedi P; Kumari P; Ghanta P; Ghosh B; Biswas S
Nanomedicine (Lond); 2017 Jan; 12(1):43-58. PubMed ID: 27879153
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer Therapy by VSVMP Gene Mediated by a Paclitaxel-Enhanced Nanoparticle.
Long J; Yang Y; Kang T; Zhao W; Cheng H; Wu Y; Du T; Liu B; Li Y; Luo F; Gou M
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39152-39164. PubMed ID: 28944654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
